Skip to resources

Knowledge Center

What are you working on today?

Posters, case studies and webinar replays from GenEvolutioN’s scientific team — pick the audience that matches your work to see relevant resources.

Or browse all resources →

All resources

Showing 12 of 14 resources

Legitimacy

Our science under independent supervision

Every resource you find here is backed by certified protocols and accredited laboratory practices.

  • République Française

    French government recognition

  • COFRAC

    French accreditation body

  • ANSM

    Health authority inspection

  • ISO 17025

    Laboratory accreditation

  • GLP

    Good Laboratory Practice

  • JEI

    Innovative young enterprise

  • CIR

    R&D tax credit approval

  • Cosmetic Valley

    Cluster member

FAQ

Questions our visitors ask

What industries do you serve?
Pharmaceuticals, cosmetics, medical devices, food, agro-science and chemicals. Our in-vitro testing solutions are designed to meet global regulatory requirements (OECD, FDA, EMA, REACH) across each of these sectors.
What makes GenEvolutioN different from other CROs?
We are a fully independent CRO specialized in in-vitro genetic toxicology, founded by former Sanofi and Covance experts. Our edge: human cell and reconstructed-tissue models, miniaturized assays, custom study designs, and direct access to our scientific team throughout each project.
Are your studies GLP-compliant and accredited?
Yes. Our laboratories are GLP-compliant, inspected by the ANSM (French Health Authority), and COFRAC-certified under ISO 17025. Every study referenced in this Knowledge Center was conducted under these standards unless explicitly noted otherwise.
Do you support non-animal testing?
Yes — exclusively. We focus on alternative, ethical and predictive in-vitro methodologies (human cells, reconstructed tissues, next-generation sequencing) to deliver reliable safety assessments while reducing animal-testing dependency.
How do I start a project with GenEvolutioN?
Contact us with a short brief of your project. Our team will propose a tailored study design aligned with GLP and your regulatory targets, then drive transparent execution with regular updates, direct access to our scientists, and full regulatory reporting support.